Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma

Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma

US Patent 7598288 · Granted Oct 6, 2009

Estimated economic value: $522,752,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices, systems, and methods for modeling ocular translaminar pressure gradient2023
Transferrin/transferrin receptor-mediated siRNA delivery2018
NPR-B agonists2018
Methods of treating ophthalmic diseases using NPR-B agonists2017
Methods of treating ophthalmic diseases using NPR-B agonists2017
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions2017
NPR-B agonists2017
Transferrin/transferrin receptor-mediated siRNA delivery2017
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2017
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2017
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma2017
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions2016